Search Results

Brian Bender About Dr. Brian Bender Dr. Between undergraduate and graduate school Brian worked as a technician in an academic lab before moving Brian is involved in organizing the GRC/GRS Molecular Pharmacology meeting, which has been postponed Brian is one of the organizers of the upcoming Transatlantic ECI GPCR Symposium . Dr. Brian Bender on the web LinkedIn Twitter ResearchGate Dr.GPCR Member Google Scholar Dr.

<< Back to podcast list Strategic Partner(s) Brian Shoichet About Dr. Brian Shoichet BSc in Chemistry from MIT, Ph.D. with Tack Kuntz at UCSF; Postdoc with Brian Matthews Brian Shoichet on the web Google Scholar Shoichet Lab Twitter Dr.

Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr.

Brian Arey About this episode Brian Arey is Senior Director of Mechanistic Pharmacology within Leads Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular I sat down with Brian to chat about GPCRs, working in the industry, and being a leader. Brian Arey on the web LinkedIn ResearchGate Pubmed Dr.

Brian Hudson About Brian Hudson Brian is a lecturer in the School of Molecular Biosciences at the University Brian Hudson on the web University of Glasgow Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass

Kathryn E Livingston About Dr. Kathryn E Livingston Dr. Kathryn E Livingston is currently a Product Manager at Gator Bio , a biotechnology company providing Kathryn E Livingston on the web LinkedIn ResearchGate Pubmed Google Scholar Dr.

David E. David E.

HSP90 runs opposite programs in brain and spinal cord. Block it in the brain and antinociception collapses. Brian Blagg at Notre Dame on β-and-GRP94-selective compounds has produced proof-of-concept IV data that Brian Blagg's KU-32 actually promotes neuronal survival in diabetic peripheral neuropathy and is now "The brain always wins.

the mechanisms of action and regulation of hormones and neurotransmitters and how they might underlie brain Brian Kolbilka (1987) Dr. Frederik Leeb-Lundberg (1984) Dr. Robert Lefkowitz (1973) Dr.

Brian Kobilka's lab at Stanford University, USA.

Brian Kobilka at Stanford University at the end of 2017 for postdoctoral work. He chose Brian's lab due to his interest in studying conformational changes. John shared his experience of reaching out to and securing a position in Brian's lab. John explained the collaborative culture in Brian's lab, where individuals are encouraged to pursue projects

Brian Shoichet at UCSF.

Brian Kobilka , studying the dimerization of GPCRs. Dr.

Brian Kobilka's lab at Stanford University and the SFMB laboratory at the Université Libre de Bruxelles

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

Brian Kobilka . Bob doesn’t really need an introduction since his reputation precedes him.

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

GPCR ecosystem 32:28 Q&A — preparing an episode, funding, and what's next 46:53 Recording Brian Roth "Brian throughout his career was told so many times that he should quit science.

to Scripps Research and UCSF, where he was first introduced to GPCRs and mentored by pioneers like Brian

the beta2-adrenergic receptor (beta2AR)-G protein complex, team effort with long time collaborator Brian

Brian Kobilka , 2012 Nobel Laureate in Chemistry.

David Hodson on visualizing GLP-1 and GIP receptors in pancreatic islets and brain circuits to advance obesity. << Back to podcast list Strategic Partner(s) Visualizing GLP-1 & GIP Receptors in Islets and Brain Professor David Hodson discusses how GLP-1 and GIP receptors regulate metabolism across the pancreas and brain Why this matters How receptor distribution in islets and brain circuits shapes incretin hormone drug

They reviewed significant early papers related to the topic, including work by Brian Roth, Terry Kenakin

Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well

Bryan Roth on the DARPA-funded effort to design a non-psychedelic psychedelic for depression — and why Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic Psilocybin is in Phase 3 trials for Bryan leads a $26.9 Million project to create better psychiatric medications, among other things. Join me and learn more about Bryan and his work. Dr. Bryan Roth on the web UNC School of Medicine / Pharmacology Roth Lab Roth Leads $26.9 Million Project

Brian Kolbika of Stanford University. Join us and learn more about Dr.

Bryan Roth, Dr. Robert Lefkowitz, Dr. Fiona Marshall, Dr. Sam Hoare, Dr. Graciela Pineyro, Dr. Brian Kobilka, and many other amazing scientists. What is the format of the Dr.GPCR Podcast?

pathways to inhibit pathogen transmission, highlighting unexpected links between mosquito and human gut-brain How dissecting receptor function in non-neuronal tissues uncovers new parallels to human gut-brain communication of circadian behaviors in Drosophila , with a specific focus on how GPCR family members orchestrate brain

Instructor Andrew Tobin directs translational GPCR research focused on generating new medicines for brain

examined the role of organic cation transporter 3 (OCT3) in the regulation of monoamine signaling in the brain